Qureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for treating idiopathic pulmonary fibrosis (IPF). The trial’s primary objective ...

According to a recent study, roughly one in five of idiopathic pulmonary fibrosis deaths might be related to occupational exposures.

Post-COVID pulmonary fibrosis, which involves scarring of the lungs that can worsen over time and may require a lung ...

Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

Marit's chronic, incurable lung disease has worsened, meaning she may have to change her schedule at short notice.

Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...

Pirfenidone use in patients with idiopathic pulmonary fibrosis may be linked to a lower incidence of lung cancer. Learn more.

Crown Princess Mette-Marit is rearranging her royal responsibilities as her chronic lung disease has "progressed," the Royal ...

The company’s stock price has dropped to around $1.38 per share after its IPF therapy trial was stopped for safety.

When you buy through links on our articles, Future and its syndication partners may earn a commission.